Latest Articles

NICE Approves First-Ever Daily Pill for Endometriosis Treatment - geneonline

NICE Approves First-Ever Daily Pill for Endometriosis Treatment geneonline

NICE recommends first combination pill for long-term treatment of endometriosis - The Pharmaceutical Journal

NICE recommends first combination pill for long-term treatment of endometriosis The Pharmaceutical Journal

NICE recommends innovative endometriosis pill - European Pharmaceutical Review

NICE recommends innovative endometriosis pill European Pharmaceutical Review

NICE recommends Gideon Richter’s Ryeqo as first daily pill for endometriosis - PMLiVE

NICE recommends Gideon Richter’s Ryeqo as first daily pill for endometriosis PMLiVE

NICE approves daily pill for endometriosis where other treatments have failed - Pulse

NICE approves daily pill for endometriosis where other treatments have failed Pulse

First daily pill for endometriosis approved for NHS use | National Institute for Health and Clinical Excellence (NICE) - WiredGov

First daily pill for endometriosis approved for NHS use | National Institute for Health and Clinical Excellence (NICE) WiredGov

First ever daily pill to treat endometriosis approved by NICE - Pharmacy Magazine

First ever daily pill to treat endometriosis approved by NICE Pharmacy Magazine

First daily pill for endometriosis approved for NHS use - NICE

First daily pill for endometriosis approved for NHS use NICE

Diagnosis and management of endometriosis: summary of updated NICE guidance.

Macranthoidin B restrains the epithelial-mesenchymal transition through COX-2/PGE2 pathway in endometriosis.

Macranthoidin B is one of the primary and unique triterpenoid saponin metabolites from Lonicera macranthoides Hand. -Mazz, which is used to treat endometriosis (EMS) in traditional Chinese medicine. However, the …